Open Access Open Access  Restricted Access Subscription or Fee Access

A Prospective Observational Study On Outcomes Of Acute Myocardial Infarction Patient Undergoing Thrombolysis At Tertiary Care Hospital

Akangksha Gajanan Ingole, PATHAN ADIBA M. MANSOOR, KELGAONKAR PRAJAKTA NANDKISHOR

Abstract


Background - Cardiovascular diseases including acute myocardial infarction, heart failure and other related risk factors are on the rise. This heart disease is generating a high burden of coronary heart diseases on health care services and becoming a leading cause of death in developing countries.  Health information is an integral part of patients education and ultimately for patient care. Thus understanding information needs of heart patients is seriously important and essential in ensuring quality care, controlling heart diseases and improving self care abilities of heart patients alongside the advanced medication and treatment and strategies. For this purpose we conducted a prospective observational study on outcomes of acute myocardial infarction patients undergoing thrombolysis. Result – In this study we observed that 63% male population was affected with AMI. Male population is more prone to MI than female population. Also, 33.33% patients are in between 51-60 years of age group. Also, 42% patients received thrombolytic therapy within 30min to 1hour of administration to hospital and also, the mostly used thrombolytic drug is streptokinase (67%) and also, after receiving the thrombolytic therapy about 24% patients underwent hypotensive condition[cardiogenic shock]. Conclusion - In this observational study we found that patients with acute MI undergoing thrombolytic therapy within 1 hours is more effective to reduce further cardiac related complications. We also observed that patients having high levels of cholesterol are at high risk of developing acute myocardial infarction.

Keywords


Cardiovascular diseases, myocardial infarction, thrombolysis, thrombolytic therapy, cardiogenic shock.

Full Text:

PDF

References


Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol. 2011;40(1):139-146. doi:10.1093/ije/dyq165

Ort EP. H E A LT H. Published online 2002.

Cureus Incidence of Acute Myocardial Infarction in Patients Presenting With Cerebrovascular Accident in a Tertiary Care Centre in Eastern India Article.

Acute Myocardial Infarction (MI) - Cardiovascular Disorders - MSD Manual Professional Edition.

MI - Secondary Prevention Secondary Prevention in Primary and Secondary Care for Patients Following a Myocardial Infarction [Internet] - PubMed.

Dauerman HL, Pinto DS, Ho KKL, et al. Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials. Catheter CardiovascInterv. 2000;49(3):237-243. doi:10.1002/(SICI)1522-726X(200003)49:3<237::AID-CCD1>3.0.CO;2-7

Myocardial Infarction Symptoms and Treatments - PubMed.

Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer An updated systematic evidence review for the U.

Aspirin for the Primary Prevention of Cardiovascular Events A Systematic Evidence Review for the U.

Bandara R, Medagama A, Munasinghe R, Dinamithra N, Subasinghe A. Management and outcomes of acute ST-segment-elevation myocardial infarction at a tertiary-care hospital in Sri Lanka : an observational study. Published online 2015:1-7.

Infarction AM. Complications of Acute Myocardial Infarction. :1-5. 12.Intracranial Hemorrhage Associated With Thrombolytic Therapy for Elderly Patients With Acute Myocardial Infarction _ Stroke.

Thrombolytic therapy: MedlinePlus Medical Encyclopedia. http://www.nlm.nih.gov/medlineplus/ency/article/007089.htm

Soumerai SB, McLaughlin TJ, Ross-Degnan D, Christiansen CL, Gurwitz JH. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: Cause for concern in the old-old. Arch Intern Med. 2002;162(5):561-568. doi:10.1001/archinte.162.5.561


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Research & Reviews: A Journal of Pharmacology